Literature DB >> 16443286

Dopamine in neurotoxicity and neuroprotection: what do D2 receptors have to do with it?

Yuri Bozzi1, Emiliana Borrelli.   

Abstract

Accurate control of dopamine levels and/or the resulting dopamine-receptor interaction is essential for brain function. Indeed, several human neurological and psychiatric disorders are characterized by dysfunctions of the dopaminergic system. Dopamine has been reported to exert either protective or toxic effects on neurons, yet it is unclear whether these effects are receptor-dependent and, if so, which dopamine receptor could be involved. The D(2) dopamine receptor occupies a privileged position because its signalling might be neuroprotective in human diseases, such as Parkinson's disease, ischaemia and epilepsy. Unravelling the role of D(2) receptors in neuronal death and survival might be central to understanding the mechanisms that underlie several neuropathologies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16443286     DOI: 10.1016/j.tins.2006.01.002

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  58 in total

1.  Total and mitochondrial nitrosative stress, decreased brain-derived neurotrophic factor (BDNF) levels and glutamate uptake, and evidence of endoplasmic reticulum stress in the hippocampus of vitamin A-treated rats.

Authors:  Marcos Roberto de Oliveira; Ricardo Fagundes da Rocha; Laura Stertz; Gabriel Rodrigo Fries; Diogo Losch de Oliveira; Flávio Kapczinski; José Cláudio Fonseca Moreira
Journal:  Neurochem Res       Date:  2010-12-28       Impact factor: 3.996

Review 2.  Nur77 and retinoid X receptors: crucial factors in dopamine-related neuroadaptation.

Authors:  Daniel Lévesque; Claude Rouillard
Journal:  Trends Neurosci       Date:  2006-11-28       Impact factor: 13.837

3.  Inhibition of the dopamine D1 receptor signaling by PSD-95.

Authors:  Jingping Zhang; Angel Vinuela; Mark H Neely; Penelope J Hallett; Seth G N Grant; Gregory M Miller; Ole Isacson; Marc G Caron; Wei-Dong Yao
Journal:  J Biol Chem       Date:  2007-03-16       Impact factor: 5.157

Review 4.  Neurobehavioural and molecular changes induced by methylmercury exposure during development.

Authors:  Carolina Johansson; Anna F Castoldi; Natalia Onishchenko; Luigi Manzo; Marie Vahter; Sandra Ceccatelli
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

Review 5.  Neuroprotection for ischemic stroke: past, present and future.

Authors:  Myron D Ginsberg
Journal:  Neuropharmacology       Date:  2008-03-04       Impact factor: 5.250

Review 6.  Molecular mechanisms of go signaling.

Authors:  Meisheng Jiang; Neil S Bajpayee
Journal:  Neurosignals       Date:  2009-02-12

7.  Common key-signals in learning and neurodegeneration: focus on excito-amino acids, beta-amyloid peptides and alpha-synuclein.

Authors:  L F Agnati; G Leo; S Genedani; L Piron; A Rivera; D Guidolin; K Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2008-11-19       Impact factor: 3.575

8.  Selective degeneration of dopaminergic neurons by MPP(+) and its rescue by D2 autoreceptors in Drosophila primary culture.

Authors:  Lyle Wiemerslage; Bradley J Schultz; Archan Ganguly; Daewoo Lee
Journal:  J Neurochem       Date:  2013-03-24       Impact factor: 5.372

9.  Dopamine promotes cathepsin B-mediated amyloid precursor protein degradation by reactive oxygen species-sensitive mechanism in neuronal cell.

Authors:  Sanju Kumari; Abhishek Mukherjee; Chinmay K Mukhopadhyay
Journal:  Mol Cell Biochem       Date:  2018-10-22       Impact factor: 3.396

10.  Alpha-synuclein disrupted dopamine homeostasis leads to dopaminergic neuron degeneration in Caenorhabditis elegans.

Authors:  Pengxiu Cao; Yiyuan Yuan; Elizabeth A Pehek; Alex R Moise; Ying Huang; Krzysztof Palczewski; Zhaoyang Feng
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.